These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 26618478)
1. Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics? Fiscella K; Winters P; Farah S; Sanders M; Mohile SG PLoS One; 2015; 10(11):e0143789. PubMed ID: 26618478 [TBL] [Abstract][Full Text] [Related]
2. Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates. Pinsky PF; Lau YK; Doubeni CA Chest; 2021 Jul; 160(1):341-350. PubMed ID: 33545164 [TBL] [Abstract][Full Text] [Related]
3. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups. Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111 [TBL] [Abstract][Full Text] [Related]
4. Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility. Landy R; Gomez I; Caverly TJ; Kawamoto K; Rivera MP; Robbins HA; Young CD; Chaturvedi AK; Cheung LC; Katki HA JAMA Netw Open; 2023 Sep; 6(9):e2331155. PubMed ID: 37721755 [TBL] [Abstract][Full Text] [Related]
5. Revisiting the lung cancer screening eligibility criteria to promote equity for Black individuals. Gudina AT; Kamen C; Hardy SJ; Kehoe L; Culakova E; Cupertino AP Lung Cancer; 2024 May; 191():107539. PubMed ID: 38552545 [TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act. Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031 [TBL] [Abstract][Full Text] [Related]
7. Eligibility Criteria for Lower Extremity Joint Replacement May Worsen Racial and Socioeconomic Disparities. Wang AY; Wong MS; Humbyrd CJ Clin Orthop Relat Res; 2018 Dec; 476(12):2301-2308. PubMed ID: 30303879 [TBL] [Abstract][Full Text] [Related]
8. Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population. Wang J; Surbhi S; Zhang Z; Spivey CA; Chisholm-Burns M Res Social Adm Pharm; 2014; 10(6):904-917. PubMed ID: 25458405 [TBL] [Abstract][Full Text] [Related]
9. Persistent race- and sex-based disparities in lung cancer screening eligibility. Potter AL; Senthil P; Srinivasan D; Raman V; Kumar A; Haridas C; Mathey-Andrews C; Zheng W; Jeffrey Yang CF J Thorac Cardiovasc Surg; 2024 Jul; 168(1):248-260.e2. PubMed ID: 37863179 [TBL] [Abstract][Full Text] [Related]
10. Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria. Wang J; Qiao Y; Tina Shih YC; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC Res Social Adm Pharm; 2014; 10(1):106-25. PubMed ID: 23759673 [TBL] [Abstract][Full Text] [Related]
11. Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma. Lu D; Qiao Y; Johnson KC; Wang J J Asthma; 2017 Jun; 54(5):504-513. PubMed ID: 27676212 [TBL] [Abstract][Full Text] [Related]
12. Historical trend of disparity implications of Medicare MTM eligibility criteria. Wang J; Qiao Y Res Social Adm Pharm; 2013; 9(6):758-69. PubMed ID: 23062785 [TBL] [Abstract][Full Text] [Related]
13. Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Pinsky PF; Ford M; Gamito E; Higgins D; Jenkins V; Lamerato L; Tenorio S; Marcus PM; Gohagan JK J Natl Med Assoc; 2008 Mar; 100(3):291-8. PubMed ID: 18390022 [TBL] [Abstract][Full Text] [Related]
14. Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population. Wang J; Brown LM; Hong SH J Am Pharm Assoc (2003); 2012; 52(5):e87-96. PubMed ID: 23023863 [TBL] [Abstract][Full Text] [Related]
15. Disparities of National Lung Cancer Screening Guidelines in the US Population. Han SS; Chow E; Ten Haaf K; Toumazis I; Cao P; Bastani M; Tammemagi M; Jeon J; Feuer EJ; Meza R; Plevritis SK J Natl Cancer Inst; 2020 Nov; 112(11):1136-1142. PubMed ID: 32040195 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations. Reese TJ; Schlechter CR; Potter LN; Kawamoto K; Del Fiol G; Lam CY; Wetter DW JAMA Netw Open; 2021 Jan; 4(1):e2033769. PubMed ID: 33433600 [TBL] [Abstract][Full Text] [Related]
17. Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US. Choi E; Ding VY; Luo SJ; Ten Haaf K; Wu JT; Aredo JV; Wilkens LR; Freedman ND; Backhus LM; Leung AN; Meza R; Lui NS; Haiman CA; Park SL; Le Marchand L; Neal JW; Cheng I; Wakelee HA; Tammemägi MC; Han SS JAMA Oncol; 2023 Dec; 9(12):1640-1648. PubMed ID: 37883107 [TBL] [Abstract][Full Text] [Related]
18. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria. Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436 [TBL] [Abstract][Full Text] [Related]
19. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria. Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946 [No Abstract] [Full Text] [Related]